Trial NCT01406704

View at ClinicalTrials.gov 
Org. Study IDs: KCMC-04-14

Last trial update was posted on 2011-08-19

MeSH Interventions

Rosiglitazone Thioctic Acid

MeSH Conditions

Fatty Liver Hepatitis Non-alcoholic Fatty Liver Disease

Other Conditions

NASH (Non-alcoholic Steato-hepatitis)

Stopping Reasons

because of withdrawal of Avandia sale due to its risks outweigh its benefits

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID